[go: up one dir, main page]

CN101606955B - Tamariskoid spikemoss herb effective part for reducing blood lipid, extraction method and application thereof, and extraction method of amentoflavone - Google Patents

Tamariskoid spikemoss herb effective part for reducing blood lipid, extraction method and application thereof, and extraction method of amentoflavone Download PDF

Info

Publication number
CN101606955B
CN101606955B CN2008100500543A CN200810050054A CN101606955B CN 101606955 B CN101606955 B CN 101606955B CN 2008100500543 A CN2008100500543 A CN 2008100500543A CN 200810050054 A CN200810050054 A CN 200810050054A CN 101606955 B CN101606955 B CN 101606955B
Authority
CN
China
Prior art keywords
selaginella
ethyl acetate
blood lipid
effective part
extraction method
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CN2008100500543A
Other languages
Chinese (zh)
Other versions
CN101606955A (en
Inventor
康文艺
贺光东
郭曙光
姬志强
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Henan University
Original Assignee
Henan University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Henan University filed Critical Henan University
Priority to CN2008100500543A priority Critical patent/CN101606955B/en
Publication of CN101606955A publication Critical patent/CN101606955A/en
Application granted granted Critical
Publication of CN101606955B publication Critical patent/CN101606955B/en
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Landscapes

  • Medicines Containing Plant Substances (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

The invention discloses a tamariskoid spikemoss herb effective part for reducing blood lipid, and an extraction method and application thereof. The effective part is an ethyl acetate part obtained by extracting tamariskoid spikemoss herb by acetone water, concentrating and extracting by ethyl acetate. The tamariskoid spikemoss herb effective part for reducing blood lipid is obtained by extracting from lipid solubility part of tamariskoid spikemoss herb and the tamariskoid spikemoss herb is distributed widely in nature, so that the raw material is easy to obtain and low in cost. In addition, the extraction method has simple technological process and easy operation. Experiment shows that the amentoflavone obtained by further extracting the tamariskoid spikemoss herb effective part for reducing blood lipid has good function of reducing blood lipid. Experiment in vivo shows that the blood lipid level can be reduced by reducing serum total cholesterol and low-density lipoprotein cholesterol of hyperlipidemic mouse. The amentoflavone has higher extraction rate, and the once extraction rate can reach as high as 30 to 40 percent.

Description

卷柏降血脂有效部位及其提取方法和应用以及穗花衫双黄酮的提取方法The effective parts of Selaginella chinensis for lowering blood fat, its extraction method and application, and the extraction method of abiflavonoids from Selaginella

技术领域 technical field

本发明涉及了一种从卷柏脂溶性部位提取降血脂有效部位——乙酸乙酯部位,同时,还涉及该有效部位的提取方法和应用;另外,还涉及一种该乙酸乙酯有效部位经进一步提取制得穗花衫双黄酮的提取方法。The present invention relates to a method for extracting the effective part for lowering blood fat from the fat-soluble part of Selaginella chinensis - ethyl acetate part, and also relates to the extraction method and application of the effective part; in addition, it also relates to the effective part of ethyl acetate through The method for further extracting and preparing the flavonoids.

背景技术 Background technique

高脂血症(Hyperlipaemia,HLP)主要是指血清总胆固醇(TC)或甘油三酯(TG)水平过高和/或血清高密度脂蛋白——胆固醇(HDL-C)水平过低。高脂血症是中老年的常见病和多发病,随着人们生活水平的提高和生活习惯的改变,该病的发病率明显增加,发病的年龄也有所提前。高脂血症所引起的动脉粥样硬化是造成冠心病、高血压和脑血管疾病的主要原因,严重危害到了人类的生命健康。目前,西药调节血脂虽有肯定的疗效,但有不同程度的副作用,且作用靶点单一。西药他汀类是目前公认为调脂最有效并广泛应用的药物,但具有肝脏和肌肉毒性等副作用。近年来,中药调血脂以其疗效好、副作用小的优势而成为研究的热点。Hyperlipaemia (Hyperlipaemia, HLP) mainly refers to serum total cholesterol (TC) or triglyceride (TG) levels are too high and/or serum high-density lipoprotein-cholesterol (HDL-C) levels are too low. Hyperlipidemia is a common and frequently-occurring disease in middle-aged and elderly people. With the improvement of people's living standards and changes in living habits, the incidence of this disease has increased significantly, and the age of onset has also advanced. Atherosclerosis caused by hyperlipidemia is the main cause of coronary heart disease, hypertension and cerebrovascular disease, which seriously endangers human life and health. At present, although Western medicines have certain curative effects on regulating blood lipids, they have side effects of varying degrees, and their targets are single. Western medicine statins are currently recognized as the most effective and widely used drugs for lipid-lowering, but they have side effects such as liver and muscle toxicity. In recent years, TCM blood lipid regulation has become a research focus due to its advantages of good curative effect and few side effects.

卷柏为蕨类植物门卷柏科(Selaginellaceae)卷柏属(Selaginella)植物,约有700种,广泛分布于全世界。我国约有50种,盛产于全国各地。2005年版《中华人民共和国药典》收载了两个品种:卷柏Selaginella tamariscina(Beauv.)Spring;垫装卷柏S.pulvinata(Hook.et Grev.)Maxim.。卷柏是我国传统中药材,早在《本经》中就有记载,列为上品,功能为:活血通经,破血散结。卷柏全草入药,卷柏作为民间传统中药材,药用历史悠久。由于传统药物的服用方法多为水煎煮法,现代药理研究也多用水煎煮液整体研究,发现水煎液在抗肿瘤、免疫、止血等方面均有很好的药理活性。但对其脂溶性部位研究较少,特别是在降血脂方面的研究尚未见报道。Selaginella is a plant of the genus Selaginella (Selaginellaceae) of the fern family Selaginellaceae, and there are about 700 species, which are widely distributed all over the world. There are about 50 species in my country, which abound in all parts of the country. The 2005 edition of "The Pharmacopoeia of the People's Republic of China" recorded two varieties: Selaginella tamariscina (Beauv.) Spring; mat-packed Selaginella tamariscina (Hook.et Grev.) Maxim. Selaginella is a traditional Chinese medicinal material in my country. It has been recorded as early as in "The Classic", and it is listed as a top grade. The whole herb of Selaginella is used as medicine, and Selaginella is a folk traditional Chinese medicinal material with a long history of medicinal use. Since traditional medicines are mostly taken by decoction, modern pharmacological research also uses decoction as a whole, and it is found that decoction has good pharmacological activities in anti-tumor, immunity, and hemostasis. However, there are few studies on its fat-soluble parts, especially the research on lowering blood lipids has not been reported.

穗花杉双黄酮(Amentoflavone)又名阿曼托双黄酮,是一种从天然植物中分离纯化得到的双黄酮类化合物,分子式为C30H18O10,分子量538,植物来源广泛,药理活性明显。在很多种中草药如银杏叶、贯叶连翘中均存在,而卷柏(包括卷柏、垫装卷柏、中华卷柏和江南卷柏等)中穗花杉双黄酮的含量又远远高于其他中草药。文献报道穗花杉双黄酮具有抗病毒、抗炎、抗癫痫、神经细胞保护、促Ca2+释放活性等活性。目前,穗花杉双黄酮的提取方法工艺过程较为繁锁,成本也相对较高。Amentoflavone, also known as Amentoflavone, is a kind of biflavone compound isolated and purified from natural plants, with a molecular formula of C 30 H 18 O 10 and a molecular weight of 538. It has a wide range of plant sources and has obvious pharmacological activity. It exists in many kinds of Chinese herbal medicines such as Ginkgo biloba and Hypericum perforatum, and the content of biflavonoids in Selaginella spica (including Selaginella, Selaginella mat, Selaginella chinensis and Selaginella jiangnan, etc.) is much higher than other Chinese herbal medicines . It has been reported in the literature that the amiflavones of Suichata spiconiae have antiviral, anti-inflammatory, anti-epileptic, nerve cell protection, and Ca 2+ release-promoting activities. At present, the process of extracting the biflavonoids of Suicha spiconiae is relatively cumbersome, and the cost is relatively high.

发明内容 Contents of the invention

本发明的目的在于提供一种从卷柏脂溶性部位提取得到卷柏降血脂有效部位,即乙酸乙酯部位。The object of the present invention is to provide an effective part of Selaginella chinensis for lowering blood fat obtained by extracting the fat-soluble part of Selaginella chinensis, ie the ethyl acetate part.

同时,本发明的目的还在于提供一种该卷柏降血脂有效部位的提取方法。At the same time, the purpose of the present invention is also to provide a method for extracting the effective part of Selaginella chinensis for reducing blood lipid.

另外,本发明的目的还在于提供一种该卷柏降血脂有效部位在降血脂方面的应用。In addition, the object of the present invention is also to provide an application of the effective fraction of Selaginella chinensis for lowering blood fat.

本发明的目的还在于提供了一种可以利用该卷柏降血脂有效部位经进一步提取制备穗花衫双黄酮的方法。The purpose of the present invention is also to provide a method for further extracting the effective parts of Selaginella chinensis for reducing blood lipids to prepare spikenin flavonoids.

为了实现上述目的,本发明的技术方案采用了一种卷柏降血脂有效部位,该有效部位为卷柏经丙酮水提取后经浓缩并用乙酸乙酯萃取而得的乙酸乙酯部位。In order to achieve the above object, the technical solution of the present invention adopts an effective part of Selaginella for reducing blood lipid, which is the ethyl acetate part obtained by extracting Selaginella with acetone water, concentrating and extracting with ethyl acetate.

本发明的技术方案还在于采用了一种卷柏降血脂有效部位的提取方法,包括以下步骤:将卷柏全草用丙酮与水的混合液在室温下浸提2-4次,每次6-9天,后经过滤,合并滤液减压,压强为0.1-0.15Mpa,回收溶剂得浓缩的提取物,将浓缩的提取物分散在水中,用乙酸乙酯萃取2-4次,得卷柏降血脂有效部位,即乙酸乙酯部位。The technical scheme of the present invention also lies in the adoption of a method for extracting effective parts of Selaginella chinensis for lowering blood lipids, comprising the following steps: extracting the whole Selaginella herb with a mixed solution of acetone and water at room temperature for 2-4 times, each time 6 After -9 days, after filtration, the combined filtrates are decompressed, the pressure is 0.1-0.15Mpa, the solvent is recovered to obtain a concentrated extract, the concentrated extract is dispersed in water, and extracted 2-4 times with ethyl acetate to obtain Selaginella The effective part for lowering blood fat is the ethyl acetate part.

所述的丙酮与水的体积比为丙酮∶水=(6-8)∶(2-4)。The volume ratio of the acetone to water is acetone:water=(6-8):(2-4).

进一步讲,本发明的技术方案还采用了一种穗花衫双黄酮的提取方法,其由卷柏降血脂有效部位经进一步提取而制得,具体包括以下步骤:将卷柏全草用丙酮与水的混合液在室温下浸提2-4次,每次6-9天,后经过滤,合并滤液减压,压强为0.1-0.15Mpa,回收溶剂得浓缩的提取物,将浓缩的提取物分散在水中,用乙酸乙酯萃取2-4次,得卷柏降血脂有效部位,即乙酸乙酯部位;将制得的乙酸乙酯部位进行硅胶常压柱层析,用石油醚-丙酮按体积比为10∶1-7∶3梯度洗脱,TLC检测合并含有穗花衫双黄酮部分,在Sephadex LH-20柱色谱以丙酮进行洗脱,得到穗花衫双黄酮。Furthermore, the technical solution of the present invention also adopts a method for extracting the biflavone of Selaginella, which is obtained by further extracting the effective parts of Selaginella chinensis for lowering blood fat, and specifically includes the following steps: the whole herb of Selaginella chinensis is mixed with acetone and water The mixed solution is leached 2-4 times at room temperature, each time for 6-9 days, and then filtered, the combined filtrate is reduced in pressure, the pressure is 0.1-0.15Mpa, the solvent is recovered to obtain a concentrated extract, and the concentrated extract is dispersed In water, extract 2-4 times with ethyl acetate to obtain the effective part of Selaginella chinensis for lowering blood fat, that is, the ethyl acetate part; carry out silica gel atmospheric pressure column chromatography on the prepared ethyl acetate part, and use petroleum ether-acetone according to volume Gradient elution at a ratio of 10:1-7:3, TLC detection of the combined fraction containing spikyflavones, and elution with acetone on Sephadex LH-20 column chromatography to obtain spicantone flavonoids.

所述的硅胶为200-300目。The silica gel is 200-300 mesh.

另外,本发明的技术方案还采用了卷柏降血脂有效部位在降血脂方面的应用。In addition, the technical solution of the present invention also adopts the application of the effective part of Selaginella chinensis for lowering blood fat.

本发明的卷柏降血脂有效部位是从卷柏脂溶性部位提取得到,卷柏在自然界中分布很广泛,这就使得本发明的原料易得,成本很低。另外,本发明的提取方法工艺过程简单,易操作。实验表明:利用本发明的卷柏降血脂有效部位经过进一步提取得到的穗花衫双黄酮具有很好的降血脂作用。体内实验表明能降低高脂血症小鼠的血清总胆固醇和低密度脂蛋白胆固醇,来降低血脂水平。本发明穗花衫双黄酮具有较高的提取率,一次提取率可高达30%-40%。The effective part of Selaginella for lowering blood fat of the present invention is extracted from the fat-soluble part of Selaginella, and Selaginella is widely distributed in nature, which makes the raw material of the present invention easy to obtain and low in cost. In addition, the extraction method of the present invention has a simple process and is easy to operate. Experiments show that: the biflavone obtained by further extracting the effective parts of Selaginella cypress of the present invention for lowering blood fat has a good effect of lowering blood fat. In vivo experiments have shown that it can reduce serum total cholesterol and low-density lipoprotein cholesterol in mice with hyperlipidemia to reduce blood lipid levels. The biflavone of the invention has a higher extraction rate, and the extraction rate at one time can be as high as 30%-40%.

采用本发明的卷柏降血脂有效部位——乙酸乙酯部位进一步制备而得的单体化合物经鉴定为穗花衫双黄酮,其结构式为:The monomer compound further prepared by adopting the effective part of Selaginella chinensis for lowering blood lipid-ethyl acetate part of the present invention is identified as abiflavone, and its structural formula is:

Figure S2008100500543D00031
Figure S2008100500543D00031

穗花衫双黄酮AmentoflavoneAmentoflavone

附图说明 Description of drawings

图1为穗花衫双黄酮标准品质量与峰面积的标准曲线图;Fig. 1 is the standard curve figure of Suohuashan biflavone standard substance quality and peak area;

图2为样品含量测定色谱图。Fig. 2 is the chromatogram of sample content determination.

具体实施方式 Detailed ways

实施例1Example 1

本实施例为卷柏降血脂有效部位——乙酸乙酯部位的制备方法,具体步骤如下:取干燥卷柏全草,用丙酮与水按体积比为7∶3冷浸3次,每次7天,过滤,合并滤液减压(压强为0.1Mpa)回收溶剂得浓缩提取物,将得到的浓缩提取物分散在水中,用乙酸乙酯萃取三次,得乙酸乙酯部位。This embodiment is the preparation method of the effective part of Selaginella chinensis for lowering blood fat - the ethyl acetate part. The specific steps are as follows: take the whole dry Selaginella herb and cold-soak 3 times with acetone and water at a volume ratio of 7:3, each time 7 day, filter, combine the filtrates to recover the solvent under reduced pressure (the pressure is 0.1Mpa) to obtain a concentrated extract, disperse the obtained concentrated extract in water, and extract three times with ethyl acetate to obtain the ethyl acetate part.

实施例2Example 2

本实施例为穗花衫双黄酮的提取方法,具体步骤如下:取实施例1制得的乙酸乙酯部位,进行硅胶常压柱(200-300目)层析,石油醚-丙酮按体积比为10∶1、8∶2和7∶3进行梯度洗脱(每个梯度洗脱5个柱体积,速度为5ml/秒),TLC检测合并含有穗花衫双黄酮部分,在Sephadex LH-20柱色谱以丙酮进行洗脱,得到穗花衫双黄酮纯品。The present embodiment is the extraction method of abiflavone of spikenard, and concrete steps are as follows: take the ethyl acetate part that embodiment 1 makes, carry out silica gel normal pressure column (200-300 mesh) chromatography, sherwood oil-acetone by volume ratio is 10:1, 8:2 and 7:3 for gradient elution (5 column volumes for each gradient elution, the speed is 5ml/sec), TLC detection combined with the fraction containing spikeniflavone, in Sephadex LH-20 column chromatography Elution is carried out with acetone to obtain the pure product of abiflavone.

结构鉴定:Structure Identification:

化合物穗花衫双黄酮,EIMS m/z:538(M+),270,121;1H-NMR(DMSO-d6)δ:13.10(1H,s,5-OH),13.00(1H,s,5″-OH),6.83(1H,s,H-3),6.21(1H,d,J=2.0Hz,H-6),6.48(1H,d,J=2.0Hz,H-8),8.03(1H,s,H-2′),7.17(1H,d,J=9.3Hz,H-5′),8.01(1H,d,J=9.3Hz,H-6′),6.80(1H,s,H-3″),6.42(1H,s,H-6″),7.59(2H,d,J=8.8Hz,H-2″′,6″′),6.74(2H,d,J=8.8Hz,H-3″′,5″′).13C-NMR(DMSO-d6)δ:163.8(C-2),102.9(C-3),181.7(C-4),161.5(C-5),98.9(C-6),164.1(C-7),94.0(C-8),157.4(C-9),103.7(C-10),121.0(C-1132.3(C-1′),127.8(C-2′),120.0(C-4′),116.2(C-5′),131.4(C-6′),163.7(C-2″),102.6(C-3″),182.1(C-4″),160.5(C-5″),98.6(C-6″),161.9(C-7″),104.0(C-8″),154.5(C-9″),103.7(C-10″),121.4(C-1″′),128.2(C-2″′),115.8(C-3″′),161.0(C-4″′),115.8(C-5″′),128.2(C-6″′)。Compound spicantone, EIMS m/z: 538 (M + ), 270, 121; 1 H-NMR (DMSO-d 6 ) δ: 13.10 (1H, s, 5-OH), 13.00 (1H, s, 5″-OH), 6.83 (1H, s, H-3), 6.21 (1H, d, J=2.0Hz, H-6), 6.48 (1H, d, J=2.0Hz, H-8), 8.03 (1H, s, H-2'), 7.17 (1H, d, J=9.3Hz, H-5'), 8.01 (1H, d, J=9.3Hz, H-6'), 6.80 (1H, s , H-3″), 6.42 (1H, s, H-6″), 7.59 (2H, d, J=8.8Hz, H-2″′, 6″′), 6.74 (2H, d, J=8.8 Hz, H-3″′, 5″′). 13 C-NMR (DMSO-d 6 ) δ: 163.8 (C-2), 102.9 (C-3), 181.7 (C-4), 161.5 (C- 5), 98.9(C-6), 164.1(C-7), 94.0(C-8), 157.4(C-9), 103.7(C-10), 121.0(C-1132.3(C-1′), 127.8(C-2′), 120.0(C-4′), 116.2(C-5′), 131.4(C-6′), 163.7(C-2″), 102.6(C-3″), 182.1( C-4″), 160.5 (C-5″), 98.6 (C-6″), 161.9 (C-7″), 104.0 (C-8″), 154.5 (C-9″), 103.7 (C- 10″), 121.4 (C-1″′), 128.2 (C-2″′), 115.8 (C-3″′), 161.0 (C-4″′), 115.8 (C-5″′), 128.2 (C-6"').

实施例3Example 3

本实施例为卷柏降血脂有效部位——乙酸乙酯部位及穗花衫双黄酮在降血脂方面的应用例。This example is an application example of the effective part of Selaginella chinensis for lowering blood lipid——ethyl acetate part and abiflavone of spikenard in reducing blood lipid.

体内降血脂抗氧化试验:In vivo lipid-lowering antioxidant test:

动物:昆明小鼠,空腹体重为23±2g,全部雄性。由河南省医学动物实验中心提供。Animals: Kunming mice, all males with a fasting body weight of 23±2 g. Provided by Henan Medical Animal Experiment Center.

材料与试剂:卷柏降血脂有效部位——乙酸乙酯部位、穗花衫双黄酮由河南大学天然药物研究所制备提供。决明子降脂片,吉林吉春制药有限公司批号:070501。超氧化物歧化酶(SOD)、丙二醛(MDA)测定试剂盒,南京建成生物工程研究所提供。总胆固醇(TC)、甘油三酯(TG)、高密度脂蛋白胆固醇(HDL-C)、低密度脂蛋白胆固醇(LDL-C)测定试剂盒,北京中生生物工程高技术公司提供。Materials and reagents: The effective part of Selaginella chinensis for lowering blood lipids—ethyl acetate part, and abiflavonoids of Selaginella were prepared and provided by the Institute of Natural Medicine, Henan University. Semen Cassiae Jiangzhi Tablets, Jilin Jichun Pharmaceutical Co., Ltd. Batch number: 070501. Superoxide dismutase (SOD) and malondialdehyde (MDA) assay kits were provided by Nanjing Jiancheng Bioengineering Institute. Total cholesterol (TC), triglyceride (TG), high-density lipoprotein cholesterol (HDL-C), and low-density lipoprotein cholesterol (LDL-C) assay kits were provided by Beijing Zhongsheng Bioengineering High-Tech Co., Ltd.

试验方法:experiment method:

高脂乳剂的配制:猪油40g、胆固醇20g、丙硫氧嘧啶1g、2g胆盐(配成10%溶液)、丙二醇2ml和吐温801ml,加水至100ml,超生30min。Preparation of high-fat emulsion: 40g of lard, 20g of cholesterol, 1g of propylthiouracil, 2g of bile salt (made into a 10% solution), 2ml of propylene glycol and 801ml of Tween, add water to 100ml, and supercharge for 30min.

动物分组与处理:取50只小鼠,平均体重23±2g,按实验要求分为正常对照组,高脂模型组,给药组(包括穗花衫双黄酮给药组和卷柏降血脂有效部位——乙酸乙酯部位给药组),阳性对照组(决明子降脂片)。正常对照组动物上午ig(灌胃)给于蒸馏水,下午ig 0.5%CMC-Na,高脂模型组均于每天上午ig给于高脂乳剂(0.2ml/10g·d),下午ig 0.5%CMC-Na,给药组分别于每天上午ig给于高脂乳剂(0.2ml/10g·d),下午ig给药,给药量见表2。20天后,各组小鼠均禁食12h,眼底静脉丛取血,离心分离血清用于血脂及SOD、MDA的测定。Animal grouping and treatment: Take 50 mice, with an average body weight of 23±2g, and divide them into normal control group, high-fat model group, and drug treatment group (including the group of two flavonoids administered with spicanthus and the effective part of Selaginella chinensis for reducing blood lipids) according to the experimental requirements. ——Ethyl acetate site administration group), positive control group (Semen Cassiae Jiangzhi Tablets). Animals in the normal control group were given distilled water by ig (gavage) in the morning, and 0.5% CMC-Na by ig in the afternoon. The high-fat model group was given high-fat emulsion (0.2ml/10g d) by ig every morning, and 0.5% CMC-Na by ig in the afternoon. -Na, the administration group was given high-fat emulsion (0.2ml/10g·d) in the morning ig respectively, and in the afternoon ig administration, the dosage is shown in Table 2. After 20 days, each group of mice fasted for 12h. Blood was collected from the venous plexus, and the serum was separated by centrifugation for the determination of blood lipids, SOD and MDA.

表1动物分组与处理Table 1 Animal grouping and treatment

指标测定方法:TC,TG,LDL-C,HDL-C,MDA,SOD的测定按试剂盒说明方法进行。Index determination method: TC, TG, LDL-C, HDL-C, MDA, SOD were measured according to the kit instructions.

数据处理:实验数据x±s表示,实验统计采用spss10.0统计软件进行单因素方差分析。Data processing: The experimental data expressed as x±s, and the experimental statistics were analyzed by one-way analysis of variance using spss10.0 statistical software.

结果:result:

卷柏降血脂有效部位——乙酸乙酯部位和化合物穗花衫双黄酮对高脂血症小鼠血脂的影响,结果见表2。与高脂模型对照组相比:卷柏降血脂有效部位——乙酸乙酯部位、化合物穗花衫黄酮血浆中TC、LDL-C均有所降低,数据差异有显著意义,HDL-C有显著提高,TG无显著影响;阳性对照组血浆中TC、LDL-C均有显著性降低。与阳性药组相比:卷柏降血脂有效部位——乙酸乙酯部位给药组、化合物穗花衫黄酮组能更加显著的提高血浆中HDL-C的水平。The effective parts of Selaginella for lowering blood lipids—the ethyl acetate part and the compound spikeflavone on the blood lipids of mice with hyperlipidemia, the results are shown in Table 2. Compared with the high-fat model control group: the effective part of Selaginella chinensis for lowering blood lipids - ethyl acetate part, the compound spike flavonoids, TC and LDL-C in plasma were all reduced, the data difference was significant, and HDL-C was significantly increased , TG had no significant effect; positive control group plasma TC, LDL-C were significantly reduced. Compared with the positive drug group: the effective part of Selaginella chinensis for lowering blood lipid - ethyl acetate part administration group and the compound spike flavonoid group can more significantly increase the level of HDL-C in plasma.

表2卷柏降血脂有效部位——乙酸乙酯部位与穗花衫双黄酮对营养性高脂血症小鼠血脂的作用(x±s)Table 2 The effective parts of Selaginella chinensis for lowering blood lipid——the ethyl acetate part and the effect of spikenin biflavone on the blood lipids of mice with nutritional hyperlipidemia (x±s)

  TCTC   TGTG   HDLHDL   LDLLDL   空白组blank group   3.9651±0.78583.9651±0.7858   2.7095±0.77242.7095±0.7724   0.6319±0.18160.6319±0.1816   1.6215±0.19551.6215±0.1955   模型组model group   5.9915±1.2886△△△ 5.9915±1.2886 △△△ 0.9419±0.22510.9419±0.2251   0.4309±0.1565△△ 0.4309±0.1565 △△   3.5811±1.3695△△△ 3.5811±1.3695 △△△ 阳性对照positive control 3.7332±0.8868*** 3.7332±0.8868 *** 0.8659±0.17710.8659±0.1771 0.3271±0.17370.3271±0.1737 0.6276±0.3332*** 0.6276±0.3332 *** 穗花衫双黄酮Abiflavanone 3.8587±1.1729*** 3.8587±1.1729 *** 1.1331±0.25221.1331±0.2522 1.8084±0.2808*** 1.8084±0.2808 *** 1.8909±1.1736*** 1.8909±1.1736 *** 乙酸乙酯部位Ethyl acetate site 4.0221±1.0117** 4.0221±1.0117 ** 0.9721±0.26630.9721±0.2663 1.4164±0.4264*** 1.4164±0.4264 *** 2.0875±1.0011** 2.0875±1.0011 **

注:与模型组比较:***P<0.001,**P<0.01,*P<0.05Note: Compared with the model group: *** P<0.001, ** P<0.01, * P<0.05

与空白组比较:△△△P<0.001,△△P<0.01,P<0.05Compared with blank group: △△△ P<0.001, △△ P<0.01, P<0.05

以上结果可知在穗花衫双黄酮的用量为乙酸乙酯部位二分之一时,二者对高脂血症小鼠血脂的作用基本相当,对乙酸乙酯部位中穗花衫双黄酮的含量测定,发现穗花衫双黄酮在乙酸乙酯部位的含量为31.64%,由此可知乙酸乙酯部位的主要有效成分是穗花衫双黄酮。以下是对乙酸乙酯部位中穗花衫双黄酮的含量测定。From the above results, it can be known that when the amount of abioflavone is 1/2 of the ethyl acetate part, the effects of the two on the blood lipids of hyperlipidemia mice are basically the same. It was found that the content of abiflavone in the ethyl acetate part was 31.64%, so it can be seen that the main active ingredient in the ethyl acetate part is abiflavone. The following is the determination of the content of spikantiflavone in the ethyl acetate fraction.

HPLC法测定Determination by HPLC

仪器与试剂Instruments and reagents

仪器:岛津LC-2010高效液相色谱仪,UV-2010A检测器,自动进样器,四元低压梯度泵,CLASS-vp色谱工作站,AL-104型电子天平(梅特勒-托利多),KQ3200型超声波清洗器。Instruments: Shimadzu LC-2010 high performance liquid chromatography, UV-2010A detector, autosampler, quaternary low-pressure gradient pump, CLASS-vp chromatography workstation, AL-104 electronic balance (Mettler-Toledo) , KQ3200 ultrasonic cleaner.

试剂:甲醇(色谱纯,厂家),高纯水,磷酸为分析纯,穗花山双黄酮标准品为天然产物研究所自制,纯度98%。Reagents: Methanol (chromatographically pure, manufacturer), high-purity water, phosphoric acid is analytically pure, Suihuashan biflavone standard is self-made by the Institute of Natural Products, with a purity of 98%.

色谱条件Chromatographic conditions

RP-18色谱柱(4.6mm ×250mm,5μm),Merck公司生产;流动相:甲醇∶0.1%磷酸水溶液(65∶35),流速0.8ml/min;检测波长337nm;柱温25℃,定量方法为外标峰面积法。RP-18 chromatographic column (4.6mm × 250mm, 5 μ m), produced by Merck Company; mobile phase: methanol: 0.1% phosphoric acid aqueous solution (65: 35), flow rate 0.8ml/min; detection wavelength 337nm; column temperature 25 ℃, quantitative method The external standard peak area method.

标准曲线的制定Establishment of standard curve

精密称取标准品1.2mg于10ml容量瓶中,摇匀备用。取一定量用过滤器(0.45μm)过滤得0.12mg/ml标准品溶液,分别进样1μl、3μl、5μl、7μl、10μl,将所得峰面积对双黄酮质量进行线性回归,得标准曲线Y=5E+06X-10436,r=1.000,线性范围为0.12μg~1.2μg。结果见表4,据表4做标准曲线,见图1。Accurately weigh 1.2mg of the standard substance into a 10ml volumetric flask, shake well and set aside. Take a certain amount and filter with a filter (0.45 μm) to obtain a 0.12 mg/ml standard solution, inject 1 μl, 3 μl, 5 μl, 7 μl, and 10 μl respectively, and perform linear regression on the obtained peak area to the quality of biflavones to obtain a standard curve Y= 5E+06X-10436, r=1.000, the linear range is 0.12μg~1.2μg. The results are shown in Table 4, and a standard curve was made according to Table 4, as shown in Figure 1.

表4Table 4

标准品浓度μg    峰面积Standard concentration μg Peak area

0.12            5935620.12 593562

0.36            17935630.36 1793563

0.60            29935630.60 2993563

0.84            41935630.84 4193563

1.20            59935631.20 5993563

样品测定:精密称取3mg乙酸乙酯有效部位至于10ml容量瓶中,加入甲醇8ml,超声使溶解,定容至10ml,过滤(0.45μm)的样品溶液。平行6份,含量测定色谱图见图2,其中A为标准品色谱图,B为样品色谱图。Sample determination: Accurately weigh the effective part of 3mg of ethyl acetate into a 10ml volumetric flask, add 8ml of methanol, dissolve it by ultrasonic, dilute to 10ml, filter (0.45μm) sample solution. Parallel 6 copies, the content determination chromatogram is shown in Figure 2, wherein A is the standard product chromatogram, B is the sample chromatogram.

结果:平均含量为31.64%,RSD=0.75%。Results: The average content was 31.64%, RSD=0.75%.

本发明还分别测定了卷柏、垫装卷柏、江南卷柏、中华卷柏等卷柏属卷柏中穗花衫双黄酮的含量,结果如表5所示。The present invention also separately measures the content of the biflavonoids in Selaginella genus Selaginella such as Selaginella, Pad Selaginella, Jiangnan Selaginella, and Chinese Selaginella, and the results are shown in Table 5.

表5不同种卷柏属植物中穗花衫双黄酮的含量Table 5 The content of abiflavones in different species of Selaginella plants

Figure S2008100500543D00081
Figure S2008100500543D00081

最后所应说明的是:以上实施例仅用以说明,而非限制本发明的技术方案,尽管参照上述实施例对本发明进行了详细说明,本领域的普通技术人员应当理解:依然可以对本发明进行修改或者等同替换,而不脱离本发明的精神和范围的任何修改或局部替换,其均应涵盖在本发明的权利要求范围当中。Finally, it should be noted that: the above embodiments are only used to illustrate, rather than limit the technical solution of the present invention, although the present invention has been described in detail with reference to the above embodiments, those of ordinary skill in the art should understand that: the present invention can still be carried out Any modification or equivalent replacement without departing from the spirit and scope of the present invention shall fall within the scope of the claims of the present invention.

Claims (1)

1.一种卷柏降血脂有效部位在制备降血脂药物方面的应用,其中所述的卷柏降血脂有效部位为卷柏经丙酮水提取后经浓缩并用乙酸乙酯萃取而得的乙酸乙酯部位,具体为:将卷柏全草用丙酮与水的混合液在室温下浸提2—4次,每次6—9天,后经过滤,合并滤液减压回收溶剂得浓缩的提取物,将浓缩的提取物分散在水中,用乙酸乙酯萃取2—4次,得卷柏降血脂有效部位,即乙酸乙酯部位,所述的丙酮与水的体积比为丙酮:水=(6-8):(2-4)。 1. Application of a blood lipid-lowering effective part of Selaginella in the preparation of blood lipid-lowering drug, wherein said effective part of Selaginella for reducing blood fat is ethyl acetate extracted from Selaginella acetone water and then concentrated and extracted with ethyl acetate Parts, specifically: extract the whole Selaginella herb with a mixture of acetone and water for 2-4 times at room temperature, each time for 6-9 days, then filter, combine the filtrate to recover the solvent under reduced pressure to obtain a concentrated extract, Disperse the concentrated extract in water, extract 2-4 times with ethyl acetate to obtain the effective part of Selaginella chinensis for lowering blood fat, that is, the ethyl acetate part, and the volume ratio of acetone to water is acetone:water=(6- 8): (2-4).
CN2008100500543A 2008-06-18 2008-06-18 Tamariskoid spikemoss herb effective part for reducing blood lipid, extraction method and application thereof, and extraction method of amentoflavone Expired - Fee Related CN101606955B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN2008100500543A CN101606955B (en) 2008-06-18 2008-06-18 Tamariskoid spikemoss herb effective part for reducing blood lipid, extraction method and application thereof, and extraction method of amentoflavone

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN2008100500543A CN101606955B (en) 2008-06-18 2008-06-18 Tamariskoid spikemoss herb effective part for reducing blood lipid, extraction method and application thereof, and extraction method of amentoflavone

Publications (2)

Publication Number Publication Date
CN101606955A CN101606955A (en) 2009-12-23
CN101606955B true CN101606955B (en) 2011-12-28

Family

ID=41480965

Family Applications (1)

Application Number Title Priority Date Filing Date
CN2008100500543A Expired - Fee Related CN101606955B (en) 2008-06-18 2008-06-18 Tamariskoid spikemoss herb effective part for reducing blood lipid, extraction method and application thereof, and extraction method of amentoflavone

Country Status (1)

Country Link
CN (1) CN101606955B (en)

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1562994A (en) * 2004-04-21 2005-01-12 徐州技源天然保健品有限公司 Producing technique for extracting extract products of amentoflavone

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1562994A (en) * 2004-04-21 2005-01-12 徐州技源天然保健品有限公司 Producing technique for extracting extract products of amentoflavone

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
史社坡.卷柏化学成分研究.《中国优秀博硕士学位论文全文数据库(硕士)医药卫生科技辑》.2006,E057-4,第8页最后一段. *

Also Published As

Publication number Publication date
CN101606955A (en) 2009-12-23

Similar Documents

Publication Publication Date Title
CN104257715B (en) Herba Artemisiae extract and its preparation method and application
CN101073599A (en) Total tanshinone and total phenolic acid extract in red-rooted salvia root and its production
CN102836188B (en) Folium microcotis total flavone extract and preparation method and application thereof
CN101863871B (en) Total glycosides of Rhodiola rosea, medical application and preparation method thereof
CN109232491A (en) The Preparation method and use of benzofuran compounds in a kind of Herba Serissae
CN104130226B (en) A kind of preparation method of high-content salvianolic acid B from salvia miltiorrhiza
CN105294623A (en) Sesquiterpene lactone compound, preparation method and application thereof
CN104644882A (en) Callicarpa nudiflora extract containing phenylethanoid glycoside and preparation method thereof
CN101537046A (en) Blood lipid-lowing active fractions of forsythia suspensa and preparation method and use of same
CN105037464A (en) Plant flavone compounds, and preparation method and application thereof
CN101982184B (en) Preparation method of taraxacum extract
CN101606955B (en) Tamariskoid spikemoss herb effective part for reducing blood lipid, extraction method and application thereof, and extraction method of amentoflavone
CN101606928B (en) Application of compound of amentoflavone in preparing hypolipidemic medicament
CN107243005A (en) A kind of anti-cancer composition extracted from eupatorium lindleynun var. trifoliolatum and its preparation method and application
CN102362877B (en) Application of a kind of Mishui kudzu extract
US8486914B2 (en) Hirsutella sinensis mycelia compositions and methods for treating sepsis and related inflammatory responses
CN102579422B (en) Use of flavonoids in the preparation of anti-metabolic disease medicines
CN100569234C (en) Composition of total ginkgolides with neuroprotective effect
CN1165545C (en) Method for separating and extracting total flavone from goldenrain tree plant and its application
CN102764284A (en) Sesquiterpene extract of tithonia diversifolia as well as preparation method and application thereof
CN103156893B (en) The novelty teabag of Radix Pternopetali vulgaris and extract thereof
CN106860771B (en) A kind of preparation method of gastrodia elata refined component and gastrodia elata refined component and application
Lee et al. Morphological and chemical analyses of Eriocauli Flos sold in Taiwan markets
CN103977163B (en) Medicinal composition with myocardial ischemia resisting effect, preparation method and application thereof
CN103524524B (en) Compound in a kind of shizandra berry and preparation and application thereof

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant
CF01 Termination of patent right due to non-payment of annual fee

Granted publication date: 20111228

Termination date: 20150618

EXPY Termination of patent right or utility model